openPR Logo
Press release

RSV Diagnostics Market | Pin-Point Analysis for Changing Competitive Dynamics

06-06-2018 07:57 PM CET | Health & Medicine

Press release from: Transparency Market Research

RSV Diagnostics Market | Pin-Point Analysis for Changing

Human respiratory syncytial virus (RSV) is a virus that commonly causes lower respiratory tract infection. Human respiratory syncytial virus infections are acquired during hospital visits. Infants and in young children are more prone to human respiratory syncytial virus (RSV) infection. RSV infections affect lungs and respiratory tract of an individual. In premature babies and children with previous presence of diseases, RSV infections affect heart and immune systems as well resulting in serious illness. Common symptoms of RSV infection include, cold, cough, headache and weakness. Human RSV infection is highly contagious and its mode of transfer is through liquid droplets produced during coughing and sneezing.

All the RSV diagnostics tests currently available in the market use sputum and saliva as specimen for detection of RSV infection. Based on the tests used to detect RSV infection, RSV diagnostics market is segmented into Immunofluorescence, Rapid antigen detection test, Cell culture test, Reverse transcriptase polymerase chain reaction (RT-PCR) kits, Serological tests, Others.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2080

Many clinics perform antigen detection test for diagnosis of human respiratory syncytial virus infection. In most of the cases, results of antigen detection tests are validated by cell culture tests. Antigen detection testsare 80% to 90% more sensitive than cell culture test for detection of RSV infection. Currently, reverse transcriptase polymerase chain reaction (RT-PCR) kits are also available in the market for the detection of human respiratory syncytial virus. Though serological tests are available in the market, they are less frequently used for routine diagnosis. Furthermore,based on the type of end users, The RSV Diagnosis Market is segmented as follows: Hospitals, Physicians’ offices, Commercial labs, Private Labs.

Some of the major companies contributing to global RSV diagnostics market are Becton, Dickinson and Company, Abbott Laboratories, Alere, Inc., Quidel Corporation, and Focus Diagnostics, Inc.

View Report -

https://www.transparencymarketresearch.com/rsv-diagnostics-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RSV Diagnostics Market | Pin-Point Analysis for Changing Competitive Dynamics here

News-ID: 1073218 • Views:

More Releases from Transparency Market Research

Plant Extract Market Outlook 2034: Rising Demand for Natural Ingredients to Drive Strong Global Growth
Plant Extract Market Outlook 2034: Rising Demand for Natural Ingredients to Driv …
The global plant extract market continues to gain remarkable momentum as consumers, industries, and regulatory bodies increasingly shift toward natural, sustainable, and clean-label ingredients. Valued at US$ 35.8 Bn in 2023, the industry is projected to grow at a robust CAGR of 10.5% from 2024 to 2034, ultimately reaching a significant US$ 106.6 Bn by 2034. This rapid expansion underscores the accelerating adoption of plant-derived compounds in pharmaceuticals, food and
Aroma Chemicals Market Outlook 2034: Expanding Applications and Fragrance Innovation Drive Steady Market Growth
Aroma Chemicals Market Outlook 2034: Expanding Applications and Fragrance Innova …
The global aroma chemicals market continues to expand as industries increasingly rely on fragrance ingredients to elevate product experience, redefine brand identity, and meet evolving consumer expectations. Valued at US$ 6.6 billion in 2023, the market is projected to reach US$ 11.8 billion by 2034, growing at a CAGR of 5.4% between 2024 and 2034. This consistent upward trajectory reflects rising demand across perfumery, personal care, household products, food and
Global Sulfur, Arsine, and Mercury Remover Market Forecasted at USD 2.4 Billion by 2031
Global Sulfur, Arsine, and Mercury Remover Market Forecasted at USD 2.4 Billion …
The oil and gas industry continues to evolve, driven by the twin imperatives of efficiency and environmental compliance. One of the critical challenges in this sector is the presence of hazardous compounds such as sulfur, arsine, and mercury in raw natural gas and crude oil streams. These impurities, if not properly removed, can severely damage refining equipment, reduce product quality, and pose serious health and environmental risks. As a result,
Global 2,3-Butanediol Market Outlook 2031: Industrial Diversification and Biochemical Advancements Fuel Steady Growth
Global 2,3-Butanediol Market Outlook 2031: Industrial Diversification and Bioche …
The global 2,3-butanediol market continues to gain traction as an important industrial chemical with expanding applications across pharmaceuticals, polymers, food additives, cosmetics, and bio-based materials. Valued at US$ 270.4 Mn in 2022, the industry is projected to reach US$ 363.9 Mn by 2031, reflecting a steady CAGR of 3.5% from 2023 to 2031. Although growth is moderate, increasing demand for bio-based chemicals and emerging technological advancements in microbial fermentation are

All 5 Releases


More Releases for RSV

The Rise In The Prevalence Of RSV Infection : Transformative Forces Shaping the …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Respiratory Syncytial Virus (RSV) Therapeutics Industry Market Size Be by 2025? The market size for therapeutics treating the respiratory syncytial virus (RSV) has seen significant expansion in the past few years. It is expected to surge from $1.6 billion in 2024 to $2 billion in 2025,
RSV Vaccine Market To Reach 731 million by 2040, Due To Increasing Awareness on …
According to our latest market report "RSV Vaccine Market, Till 2040 by Type of Vaccine, Route of Administration, Target Patient Population, Distribution Channel, Key Geographical Regions and Leading Players", the RSV Vaccine market size is projected to reach USD 731 million by 2040 from USD 1,149 million in current year, during the forecast period. To request quote of this report, please visit: https://www.rootsanalysis.com/reports/rsv-vaccine-market/request-quote.html In the dynamic landscape of preventive therapies for respiratory
RSV Diagnostics Market to Signify Strong Growth by 2024-2031
The RSV (Respiratory Syncytial Virus) Diagnostics market is experiencing significant growth due to the increasing prevalence of RSV infections, advancements in diagnostic technologies, and the rising demand for accurate and rapid diagnostic solutions. RSV is a common respiratory virus that causes infections in the lungs and respiratory tract, particularly affecting infants, young children, and the elderly. Market Overview The global RSV Diagnostics market is projected to witness substantial growth over the coming
Global RSV Diagnostic Products Market Size & Trends
According to a new market research report published by Global Market Estimates, the global RSV diagnostic products market is expected to grow at a CAGR of 11.4% from 2023 to 2028. Ongoing advancements in diagnostic technologies, specifically PCR and rapid point-of-care testing, play a crucial role. These advancements offer heightened accuracy, faster results, and increased accessibility, enabling prompt and precise identification of RSV infections. Browse 147 Market Data Tables and 115 Figures
Respiratory Syncytial Virus (RSV) Therapeutics Market Size to Reach USD 9080.84 …
Respiratory Syncytial Virus (RSV) Therapeutics Market Scope & Overview Respiratory Syncytial Virus (RSV) Therapeutics Market size was USD 1040.65 Million in 2022 and is expected to Reach USD 9080.84 Million by 2030 and grow at a CAGR of 31.1% over the forecast period of 2023-2030. The Respiratory Syncytial Virus (RSV) Therapeutics market is a vibrant, fiercely competitive sector that is essential to digital marketing. The demand for effective has increased as companies
Respiratory Syncytial Virus (RSV) Therapeutics Market - Conquering RSV: Advancin …
Newark, New Castle, USA: The "Respiratory Syncytial Virus (RSV) Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Respiratory Syncytial Virus (RSV) Therapeutics Market: https://www.growthplusreports.com/report/respiratory-syncytial-virus-rsv-therapeutics-market/8519 This latest report